FAILED
首站-论文投稿智能助手
典型文献
Successful liver transplantation from a donor with immune thrombocytopenia
文献摘要:
To the Editor: Immune thrombocytopenia(ITP)is an acquired autoimmune bleeding disease,which results from a combination of humoral and cell-mediated attacks on platelets and megakaryocytes[1-3].ITP patients are always presented as heterogeneous clinical bleeding manifestations.Fatal bleeding such as intracranial hemorrhage is the main cause of death,which turns the patients into potential organ donors.Several studies indicated that the donor lymphocytes secreting autoantibody may be transferred to recipients after trans-plantation[4,5].Transplantation-mediated alloimmune thrombocy-topenia(TMAT)was donor-derived thrombocytopenia after solid-organ transplantation[6].TMAT is a rare complication after trans-plantation,and the recipients of TMAT may present more severe bleeding events than the donors.A total of 6 recipients with TMAT after liver transplantation from ITP donors have been reported in-ternationally[6-11],among which 3 recipients died and 3 sur-vived.Thus,liver transplantation from ITP donors is relatively risky,and as a marginal donor organ,the use of ITP donor liver is contro-versial.There are no relevant guidelines for the safety assessment and treatment of ITP donor liver transplantation up to now.Here we reported a successful case with TMAT in liver transplant recip-ient from ITP donor in purpose of improving our understanding of TMAT.
文献关键词:
作者姓名:
Wen-Tao Yang;Jing-Sheng Ma;Hong-Fei Zhu;Lin Zhong;Qi-Gen Li;Wen-Tao Yang
作者机构:
Department of Organ Transplantation,The Second Affiliated Hospital of Nanchang University,Nanchang 330000,China
引用格式:
[1]Wen-Tao Yang;Jing-Sheng Ma;Hong-Fei Zhu;Lin Zhong;Qi-Gen Li;Wen-Tao Yang -.Successful liver transplantation from a donor with immune thrombocytopenia)[J].国际肝胆胰疾病杂志(英文版),2022(03):299-302
A类:
Immune,megakaryocytes,thrombocy,topenia,TMAT,ternationally,vived,versial
B类:
Successful,liver,transplantation,from,thrombocytopenia,To,Editor,ITP,acquired,autoimmune,bleeding,disease,which,results,combination,humoral,cell,mediated,attacks,platelets,patients,always,presented,heterogeneous,clinical,manifestations,Fatal,such,intracranial,hemorrhage,main,cause,death,turns,into,potential,organ,donors,Several,studies,indicated,that,lymphocytes,secreting,autoantibody,may,transferred,recipients,after,Transplantation,alloimmune,was,derived,solid,rare,complication,more,severe,events,than,total,have,been,reported,among,died,sur,Thus,relatively,risky,marginal,contro,There,relevant,guidelines,safety,assessment,treatment,up,now,Here,we,successful,case,purpose,improving,our,understanding
AB值:
0.445675
相似文献
Romidepsin (FK228) improves the survival of allogeneic skin grafts through downregulating the production of donor-specific antibody via suppressing the IRE1 α-XBP1 pathway
Yuliang GUO;Siyu SONG;Xiaoxiao DU;Li TIAN;Man ZHANG;Hongmin ZHOU;Zhonghua Klaus CHEN;Sheng CHANG-Institute of Organ Transplantation,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China;Key Laboratory of Organ Transplantation,Ministry of Education,NHC Key Laboratory of Organ Transplantation,Key Laboratory of Organ Transplantation,Chinese Academy of Medical Sciences,Wuhan 430030,China;Henan Key Laboratory of Digestive Organ Transplantation,Open and Key Laboratory of Hepatobiliary&Pancreatic Surgery and Digestive Organ Transplantation at Henan Universities,Zhengzhou Key Laboratory of Hepatobiliary&Pancreatic Diseases and Organ Transplantation,Department of Hepatobiliary and Pancreatic Surgery,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China;Department of Cardiothoracic and Vascular Surgery,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China
Application of regional citrate anticoagulation in patients at high risk of bleeding during intermittent hemodialysis:a prospective multicenter randomized controlled trial
Xiaoyan TANG;Dezheng CHEN;Ling ZHANG;Ping FU;Yanxia CHEN;Zhou XIAO;Xiangcheng XIAO;Weisheng PENG;Li CHENG;Yanmin ZHANG;Hongbo LI;Kehui LI;Bizhen GOU;Xin WU;Qian YU;Lijun JIAN;Zaizhi ZHU;Yu WEN;Cheng LIU;Hen XUE;Hongyu ZHANG;Xin HE;Bin YAN;Liping ZHONG;Bin HUANG;Mingying MAO-Division of Nephrology,Kidney Research Institute,West China Hospital of Sichuan University,Chengdu 610041,China;Department of Nephrology,People's Hospital of Jianyang City,Chengdu 641400,China;Department of Nephrology,the Second Affiliated Hospital of Nanchang University,Nanchang 330006,China;Department of Nephrology,Xiangya Hospital of Central South University,Changsha 410008,China;Department of Nephrology,Wuhan No.1 Hospital,Wuhan 430022,China;Department of Blood Purification,the First Affiliated Hospital of Guangxi Medical University,Nanning 530021,China;Department of Nephrology,Guiyang First People's Hospital,Guiyang 550002,China;Department of Nephrology,West China Hospital Sichuan University Jintang Hospital,Jintang 610400,China;Department of Nephrology,Meishan People's Hospital,Meishan 620020,China;Department of Nephrology,Ziyang People's Hospital,Ziyang 641300,China;Department of Nephrology,Ya'an People's Hospital,Ya'an 625000,China;Department of Nephrology,Chengdu Kangfu Kidney Disease Hospital,Chengdu 610047,China;Department of Nephrology,the First People's Hospital of Liangshan Yi Autonomous Prefecture,Xichang 615000,China
A randomized controlled trial to evaluate efficacy and safety of early conversion to a low-dose calcineurin inhibitor combined with sirolimus in renal transplant patients
Zheng Xiang;Zhang Weijie;Zhou Hua;Cao Ronghua;Shou Zhangfei;Zhang Shuwei;Cheng Ying;Chen Xuchun;Ding Chenguang;Tang Zuofu;Li Ning;Shi Shaohua;Zhou Qiang;Chen Qiuyuan;Chen Gang;Chen Zheng;Zhou Peijun;Hu Xiaopeng;Zhang Xiaodong;Na Ning;Wang Wei-Department of Urology, Capital Medical University Beijing Chaoyang Hospital, Beijing 100020, China;Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430032, China;Kidney Transplantation Dialysis Center, The Second People’s Hospital of Shanxi Province, Taiyuan, Shanxi 030012, China;Department of Organ Transplantation, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, Guangdong 510120, China;Department of Nephrology, Shulan (Hangzhou) Hospital, Hangzhou, Zhejiang 310000, China;Department of Urology, Ningbo Yinzhou Number. 2 Hospital, Ningbo, Zhejiang 315000, China;Department of Organ Transplantation, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning 110001, China;Institute of Kidney Transplantation, The First Affiliated Hospital, Medical College of Xi’an Jiaotong University, Xi’an, Shaanxi 710061, China;Department of Kidney, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong 510630, China;Department of Kidney, Southwest Hospital, The First Hospital Affiliated to The Third Military Medical University (Army Medical University), Chongqing 400000, China;Organ Transplant Center, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510260, China;Kidney Transplantation Center, Department of Urology, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200000, China
Analysis of risk factors associated with endoscopic retrograde cholangiopancreatography for patients with liver cirrhosis: a multicenter, retrospective, clinical study
Li Jielin;Hu Jiexuan;Li Peng;Wu Yongdong;Wang Yongjun;Ji Ming;Hua Haiyang;Ran Wenbin;Pan Yanglin;Zhang Shutian-Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, National Clinical Research Center for Digestive Disease, Beijing 100050, China;Department of Oncology, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China;Department of Gastroenterology, Cheng De Central Hospital, Chengde, Hebei 067000, China;Department of Gastroenterology, The Third People’s Hospital of Chengdu, Chengdu, Sichuan 610031, China;Xijing Hospital of Digestive Diseases, Air Force Medical University of People’s Liberation Army, Xi’an, Shaanxi 710032, China
Macrophage polarization is involved in liver fibrosis induced by β1-adrenoceptor autoantibody
Ye Wu;Xiongxiong Fan;Haicun Yu;Jingyi Liu;Yanru Duan;Suli Zhang;Li Yan;Yunhui Du;Huirong Liu-Department of Physiology and Pathophysiology,School of Basic Medical Sciences,Capital Medical University,Beijing 100069,China;Beijing key laboratory of metabolic disorder related cardiovascular disease,School of Basic Medical Sciences,Capital Medical University,Beijing 100069,China;Zhengzhou Central Hospital affiliated of Zhengzhou University,Zhengzhou 450000,China;Shanxi Cardiovascular Hospital,Cardiac Care Unit,Taiyuan 030024,China;Department of Pathophysiology,Institute of Basic Medical Science,Chinese Academy of Medical Sciences&Peking Union Medical College,Beijing 100005,China;Beijing Anzhen Hospital,Capital Medical University,Beijing Institute of Heart,Lung and Blood Vessel Diseases,Beijing100029,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。